Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study-Reference-Cited by-同舟云学术

Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study

Published:2018-09 Issue:3 Volume:17 Page:e489-e498
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Baretti Marina,Rimassa Lorenza^ORCID,Personeni Nicola,Giordano Laura,Tronconi Maria Chiara,Pressiani Tiziana,Bozzarelli Silvia,Santoro Armando

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference41 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening;Gross;Ann Intern Med,2006

3. Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer;Lemmens;Br J Surg,2005

4. Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?;Keating;J Clin Oncol,2008

5. Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study;Yancik;Cancer,1998

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comorbidity Patterns in Patients Newly Diagnosed With Colorectal Cancer: Network-Based Study;JMIR Public Health and Surveillance;2023-09-05

2. Management of metastatic colorectal cancer in patients ≥70 years - a single center experience;Frontiers in Oncology;2023-07-25

3. Comorbidity Patterns in Patients Newly Diagnosed With Colorectal Cancer: Network-Based Study (Preprint);2022-08-18

4. Analysis of microarray-identified genes and MicroRNAs associated with Trifluridine resistance in colorectal cancer;All Life;2022-06-01

5. Predictive risk-score model for selection of patients with high-risk stage II colon cancer for adjuvant systemic therapy;Surgery;2021-11